Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × Ramucirumab × Clear all

Phase

Status

Completed 3 Recruiting 2 Active not recruiting 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 7 Thymoma 1 Neoplasm Metastasis 1 Esophageal Neoplasms 1 Advanced Gastric Cancer 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Fluorouracil 18 Oxaliplatin 15 Capecitabine 15 Leucovorin 13 Irinotecan 11 Gemcitabine 11 Drug Therapy 11 Cetuximab 10 Radiosurgery 9 Cisplatin 9 Bevacizumab 9 Docetaxel 8 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Everolimus 6 spartalizumab 5 pembrolizumab 5 Trastuzumab 5 Sunitinib 5 S 1 (combination) 5 Cyclophosphamide 5 Chemotherapy, Adjuvant 5 Carboplatin 5 manganese chloride 4 Surgical Procedures, Operative 4 Sorafenib 4 Nivolumab 4 Immunotherapy 4 Immune Checkpoint Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03921671 2024-05-29

RELEVENT

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡